Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Sotera Health Company (SHC)

Compare
11.13
-0.53
(-4.55%)
At close: April 1 at 4:00:00 PM EDT
11.17
+0.04
+(0.36%)
After hours: April 1 at 4:26:05 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,100,441
1,100,441
1,049,288
1,003,687
931,478
Cost of Revenue
498,146
498,146
472,130
446,683
412,806
Gross Profit
602,295
602,295
577,158
557,004
518,672
Operating Expense
304,669
304,669
300,466
308,654
261,939
Operating Income
297,626
297,626
276,692
248,350
256,733
Net Non Operating Interest Income Expense
-164,691
-164,691
-142,878
-80,144
-74,192
Other Income Expense
-19,061
-19,061
-27,787
-411,317
-6,825
Pretax Income
113,874
113,874
106,027
-243,111
175,716
Tax Provision
69,476
69,476
54,651
-9,541
58,595
Net Income Common Stockholders
44,398
44,398
51,376
-233,570
116,882
Diluted NI Available to Com Stockholders
44,398
44,398
51,376
-233,570
116,882
Basic EPS
0.25
0.16
0.18
-0.83
0.41
Diluted EPS
0.25
0.16
0.18
-0.83
0.41
Basic Average Shares
282,302.50
282,784
281,008
280,096
279,228
Diluted Average Shares
284,324.50
284,906
283,222
280,096
279,382
Total Operating Income as Reported
297,626
297,626
276,692
248,350
256,733
Total Expenses
802,815
802,815
772,596
755,337
674,745
Net Income from Continuing & Discontinued Operation
44,398
44,398
51,376
-233,570
116,882
Normalized Income
63,647.93
63,647.93
79,151.61
167,792.90
131,563.12
Interest Expense
164,691
164,691
142,878
80,144
74,192
Net Interest Income
-164,691
-164,691
-142,878
-80,144
-74,192
EBIT
278,565
278,565
248,905
-162,967
249,908
EBITDA
442,202
442,202
406,830
-17,413
400,810
Reconciled Cost of Revenue
396,548
396,548
378,004
364,069
325,685
Reconciled Depreciation
163,637
163,637
157,925
145,554
150,902
Net Income from Continuing Operation Net Minority Interest
44,398
44,398
51,376
-233,570
116,882
Total Unusual Items Excluding Goodwill
-24,367
-24,367
-35,159
-417,758
-22,026
Total Unusual Items
-24,367
-24,367
-35,159
-417,758
-22,026
Normalized EBITDA
466,569
466,569
441,989
400,345
422,836
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-5,117.07
-5,117.07
-7,383.39
-16,395.10
-7,344.88
12/31/2021 - 11/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QGEN Qiagen N.V.
39.50
-1.62%
 
MYGN Myriad Genetics, Inc.
8.84
-0.34%
 
MTD Mettler-Toledo International Inc.
1,156.38
-2.08%
 
CRL Charles River Laboratories International, Inc.
145.99
-3.01%
 
IDXG Interpace Biosciences, Inc.
0.9490
-0.01%
 
GH Guardant Health, Inc.
42.47
-0.31%
 
RVTY Revvity, Inc.
104.31
-1.41%
 
ARYC Arrayit Corporation
0.0001
0.00%
 
AVCRF Avricore Health Inc.
0.0388
+17.58%
 
LZAGF Lonza Group AG
598.90
0.00%